Skip to content

Clinical trials

Pathologic Complete Response trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pathologic Complete Response Country / region: Belgium Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20121
20131
20141
20171
20181
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting2
Completed2
Unknown status2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Celgene1
Millennium Pharmaceuticals, Inc.1
The Netherlands Cancer Institute1
Universitair Ziekenhuis Brussel1
Xenikos1
Zwi Berneman1
pharmaand GmbH1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pathologic Complete Response7
Leukemia, Myeloid, Acute2
Carcinoma, Non-Small-Cell Lung1
Carcinoma, Ovarian Epithelial1
Fallopian Tube Neoplasms1
Lymphoma, Follicular1
Melanoma1
Neoplasm Metastasis1
Neoplasms1
Rectal Neoplasms1

Trials

Showing 51 to 7 of 7. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.